Agilus Diagnostics Completes Intra-Group Restructuring, Merging Subsidiaries in Scheme of Arrangement
Agilus Diagnostics Limited has approved an intra-group restructuring involving the merger of its wholly owned subsidiaries into the company itself. The move, decided during a Board meeting held on August 5, 2026, aims to consolidate operations through a defined Scheme of Arrangement.The restructuring involves two subsidiaries: Agilus Pathlabs Private Limited and DDRC Agilus Pathlabs Limited. Both companies are wholly owned by Agilus Diagnostics Limited and will be merged into the parent company under the terms of the Scheme.
As this transaction constitutes an intra-group restructuring involving the merger of wholly owned entities, no consideration is payable to any party pursuant to the Scheme of Arrangement.
The successful completion of the Scheme is subject to crucial approvals. The transaction requires subsequent approval from the jurisdictional National Company Law Tribunals or any other relevant authorities, as well as consent from the members and creditors of the companies involved.
The approved merger aims to streamline operations by bringing these subsidiary entities into Agilus Diagnostics Limited under a structured arrangement.
FORTIS Stock Price Movement
Shares of Fortis Healthcare Limited slipped today as the stock settled at ₹925.00, declining by 0.84%. The company traded a volume of 1.90 million shares during post-market activity.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.